Noveris Health Sciences is trading at CA$0.10, down 5.00%, with no clear company-specific catalyst identified for September 23, 2026.
- The latest identified company news was the September 9 annual and special meeting results; no newer CSE release was displayed.
- The broader market is modestly weaker, but the move does not clearly track biotech strength or a major index decline.